Fas and Fas ligand expression in Alzheimer's disease

Acta Neuropathologica

Volumn 102, Issue 2, 2001, Pages 121-131

  Ferrer, I ^a   Puig, B ^a,b   Krupinski, J ^a,b   Carmona, M ^a,b   Blanco, R ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer's disease; Caspases; Fas; Fas ligand

Indexed keywords

CELL NUCLEUS DNA; DNA FRAGMENT; EPITOPE; FAS ANTIGEN; FAS LIGAND; POLYCLONAL ANTIBODY; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; B LYMPHOCYTE; BRAIN NERVE CELL; CELL DEATH; CELL SURVIVAL; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATION; DYSTROPHY; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SENILE PLAQUE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 0034889518     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000325     Document Type: Article

References (64)

1. The Fas antigen and Fas-mediated apoptosis in B-cell differentiation
2. DNA damage and apoptosis in Alzheimer's disease. Colocalization with c-Jun immunoreactivity, relationship to brain area and effect of post-mortem delay
3. Mechanisms of cell death in Alzheimer's disease
4. CD95-CD95L: Can the brain learn from the immune system?
5. Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity
6. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
7. The Fas-based mechanism of lymphocytotoxicity
8. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
9. Neuropathological staging of Alzheimer-related changes
10. Portrait of an executioner: The molecular mechanism of Fas/APO-1-induced apoptosis
11. Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-α in the central nervous system
12. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ
13. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
14. p53- and CD95-associated apoptosis in neurodegenerative diseases
15. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
16. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
17. The Fas pathway in apoptosis
18. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction
19. Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is up-regulated following cerebral hypoxic-ischemic injury to the developing rat brain
20. Neurotoxicity of β-amyloid and prion peptides
21. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
22. Regulation of Fas-mediated apoptosis
23. Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors
24. Fas-ligand; privilege and peril
25. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines
26. Neuronal apoptosis induced by β-amyloid is mediated by caspase-8
27. Role of calpain- and interleukin-1β converting enzyme-like proteases in the β-amyloid-induced death of rat hippocampal neurons in culture
28. The CD95(APO-1/Fas)/CD95L system
29. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
30. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
31. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients
32. DNA damage distribution in the human brain as shown by in situ end-labeling: Area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology
33. Signalling by CD95 and TNF receptors: Not only life and death
34. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons
35. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease
36. Fas antigen mRNA induction in postischemic murine brain
37. Localization of Fas antigen mRNA induced in post-ischemic murine forebrain by in situ hybridization
38. Protection against β-amyloid toxicity in primary neurons by paclitaxel (taxol)
39. The soluble form of Fas molecule is elevated in parkinsonian brain tissue
40. Signalling by proteolysis: Death receptors induce apoptosis
41. Apoptosis mediated by the Fas system
42. Fas antigen expression in brains of patients with Alzheimer-type dementia
43. Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
44. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain?
45. CD95(Fas/Apo-1) as a receptor governing astrocytic apoptotic or inflammatory responses: A key role in brain inflammation?
46. Delayed selective motor neuron death by Fas antigen induction after spinal cord ischemia in rabbits
47. Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome
48. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
49. Amyloid beta-induced neuronal death is Bax-dependent but caspase-independent
50. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease
51. The role of Fas and related death receptors in autoimmune and other disease states
52. Expression of Fas/APO-1 during the progression of astrocytoma
53. Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme
54. Inhibition of Fas death signals by FLIPs
55. The role of antigen-presenting cell in Fas-mediated direct and bystander killing: Potential in vivo function of Fas in experimental allergic encephalomyelitis
56. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas
57. Caspase-2 mediates neuronal cell death induced by β-amyloid
58. Tumor expression of Fas ligand (CD95L) and the consequences
59. Tumor necrosis factor receptor and Fas signaling mechanisms
60. Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons
61. CD95 ligand: Lethal weapon against malignant glioma?
62. Apoptotic signal transduction: Emerging pathways
63. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides
64. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis